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Introduction
Protein kinase N1 (PKN1/PRK1) is the most abundantly expressed 
isoform of the PKN family in the central nervous system and accounts 
for 0.01% of total brain protein (1). It is widely studied for its involve-
ment in cancer (2); however, surprisingly little is known about 
the brain-specific function of this kinase, even though it was first 
isolated from human hippocampal cDNA in 1994 (3) and is partic-
ularly enriched in certain brain areas (4). In human neurons PKN is 
mainly localized to juxtanuclear, cytoplasmic, dendroplasmic, and 
pre- and postsynaptic compartments (5).
PKN1 is a serine/threonine kinase and belongs to the protein 
kinase C superfamily, sharing a characteristic C-terminal catalytic 
domain (3, 6) that requires phosphorylation by PDK-1 for activa-
tion. The N-terminal regulatory domain confers binding and reg-
ulation by RhoA/B/C, Rac1 (7), fatty acids, and phospholipids (8). 
Activation of PKN1 is also achieved by caspase-3–mediated cleav-
age, resulting in a constitutively active protein product missing the 
regulatory N-terminus (9). This form of deregulated PKN1 activa-
tion occurs during apoptosis (10) and has been linked to various 
insults to the brain (11–14). We have previously reported that PKN1 
is part of a purine-nucleoside signaling cascade involved in the 
protection of hypoxic neuronal cultures and cell lines in vitro (15, 
16). However, despite those in vitro reports and evidence on the 
generation of a constitutively active fragment, the physiological 
function of PKN1 in the nervous system in vivo is not yet known.
Using Pkn1–/– animals (17), this work set out to clarify the role 
of PKN1 in the brain. We focused on the cerebellum, which has a 
central role in motor control and coordination and is also the brain 
area with the highest PKN1 expression levels (4). The lengthy pro-
cess to achieve cerebellar maturity makes it particularly suscep-
tible to developmental abnormalities, which may finally result in 
neurodegeneration and disabilities such as cerebellar ataxia (18). 
Two excitatory afferents converge onto Purkinje cells (PCs), the 
only output neurons of the cerebellum: climbing fibers (CFs) from 
inferior olivary nuclei, and parallel fibers (PFs) from cerebellar 
granule cells (Cgcs). A hallmark in cerebellar development is the 
correct formation of the PF-PC synapse (19), which is important 
for the segregation of CF and PF territories (20, 21) and cerebellar 
long-term function (22). PF-PC synaptic dysfunctions have been 
implicated in models of spinocerebellar ataxias 1, 3, 5, and 27 and 
Friedreich’s ataxia as well as autism spectrum disorders (19, 23). 
Considering the high expression levels of PKN1 in Cgcs and PCs 
(4), we investigated the effect of Pkn1 deletion on the formation of 
PF-PC as well as CF-PC synapses during cerebellar development.
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prepared from P13–P15 WT and Pkn1–/– animals. Recordings were 
performed at room temperature to avoid intrinsic PC firing (25), 
and therefore ePSCs mainly reflect PF synapse activity (26, 27). 
Interestingly, Pkn1–/– PCs showed reduced ePSC frequencies (Fig-
ure 1E) but similar ePSC amplitudes (Supplemental Figure 1D), 
indicating differences in the number of functional synapses but 
not in presynaptic quantal content or postsynaptic receptors. Like-
wise, Pkn1–/– cerebellar slices had a reduced inhibitory PSC (iPSC) 
input (Supplemental Figure 1E), which might also be caused by a 
defective PF-ML interneuron synapse formation.
We next tested the expression of the PF-PC synaptic markers 
cerebellin 1 (Cbln1), a protein excreted by Cgcs and important for 
PF-PC synapse stabilization (22, 28), and δ2 glutamate receptor 
(GluD2), the PC postsynaptic receptor binding to extracellular 
Cbln1 (29). Consistently with a defective PF-PC synapse forma-
tion, Cbln1 expression levels were lower in P15 Pkn1–/– cerebella 
(Figure 1, F and G). GluD2 expression levels were, however, only 
marginally affected (Figure 1, F and H), suggesting a Cgc-specific 
defect. We next screened in vitro Cgcs for differences in presynap-
tic maturation and axonal outgrowth properties, since the correct 
balance between axonal growth and presynaptic differentiation is 
an essential part of synapse formation (30).
PKN1 regulates axonal outgrowth and the density of presynaptic 
sites in Cgcs in vitro. We first analyzed mature Cgc cultures (4–7 
days in vitro [DIV]) for differences in presynaptic sites, which 
appear as “en passant swellings” (31) along the axon. These var-
icosities show colocalization of TAU and the presynaptic marker 
synapsin I (Figure 2A). In Pkn1–/– Cgcs transfected with HA-tagged 
human PKN1 (hPKN1), HA staining was found around the nucleus, 
in dendrites, and along those en passant swellings of the axon (Sup-
plemental Figure 2, A and B). Interestingly, mature Pkn1–/– Cgc 
cultures had a reduced density of presynaptic sites (Figure 2B), an 
effect that could be rescued by reintroduction of hPKN1 (Figure 
2C). Pkn1 knockout also resulted in deregulated axonal outgrowth, 
as seen in elongated axons of Pkn1–/– Cgcs throughout the entire 
culture period (Figure 2D). The enhanced axonal outgrowth was 
reduced to WT levels in Pkn1–/– Cgcs transfected with hPKN1 (Fig-
ure 2E). These results point toward elongated axonal outgrowth 
at the expense of presynaptic differentiation in Pkn1–/– Cgcs. We 
therefore next screened Cgc protein extracts for differences in 
PKN1 downstream signaling molecules involved in presynaptic 
differentiation and axonal outgrowth.
Pkn1 knockout results in enhanced AKT phosphorylation and 
NeuroD2 expression in Cgcs in vitro. An important regulator of axo-
nal outgrowth is the protein kinase AKT (32), and PKN1 has been 
previously suggested to negatively regulate AKT activity (33), 
for example downstream of the B cell antigen receptor (34). We 
found that Cgcs from Pkn1–/– mice showed significantly higher 
endogenous AKT phosphorylation levels at T308 and S473 (Sup-
plemental Figure 2C). The mean phospho-AKT (p-AKT) T308 
(Figure 3A) and p-AKT S473 (Supplemental Figure 2D) intensity of 
Pkn1–/– Cgcs was consistently reduced in hPKN1-transfected cells, 
but not in GFP-transfected cells (Supplemental Figure 2E), show-
ing that the higher AKT phosphorylation was specifically caused 
by the absence of PKN1. We next tested whether Pkn1 knockout–
mediated AKT hyperactivation is the cause of elongated axonal 
outgrowth, by incubating Cgcs with the potent AKT inhibitor 
protein levels of the transcription factor neuronal differentiation-2 
(NeuroD2), thereby fine-tuning axonal outgrowth and presynaptic 
differentiation of Cgcs. Accordingly, Pkn1 deletion results in dis-
rupted PF-PC synapse formation and defective CF elimination, as 
seen in a reduced expression of the PF-PC synaptic marker cere-
bellin 1 (Cbln1), persistent multiple CF innervation, and reduced 
spontaneous PC activity. The long-term effect of Pkn1 deletion 
was further seen in cerebellar atrophy and mild ataxia in adult 
Pkn1–/– animals. Despite the rapidly increasing literature on AKT 
signaling and neurodevelopment, this is, to our knowledge, the 
first report linking developmental AKT activity with NeuroD2 
levels and cerebellar synapse formation, and we identify PKN1 as 
a regulator of this pathway.
Results
Deletion of Pkn1 leads to a defective PF-PC synapse formation and PC 
activity. We first analyzed CF growth, as an indicator of a function-
ing PF-PC synapse formation, by staining of cerebellar sections 
of postnatal day 8 (P8)–P15 WT and Pkn1–/– animals with the CF- 
specific marker vesicular glutamate transporter 2 (VGlut2) (20). 
Early during cerebellar development, PC somata are innervated 
by multiple CFs. From P9 onward a single “winner” CF starts 
dendritic translocation and expands its territory (20). Perisomatic 
CF synapse elimination occurs in an early, PF-independent phase 
(~P7–P11) and a late phase (~P12–P17), which, similar to the prox-
imal dendritic restriction of CF innervation, strictly depends on 
a functioning PF-PC synapse (21). There were no differences 
between WT and Pkn1–/– animals in VGlut2-stained CF terminals at 
P8, where they were mainly found around the PC somata (Figure 1, 
A and B). However, as compared with WT animals, cerebella of P15 
Pkn1–/– mice showed an enhanced distal extension of CF terminals 
into PF territory (Figure 1, A and B) and a defective perisomatic 
CF elimination (Figure 1, A and C). Western blot analysis further 
revealed that the ratio of VGlut2 to the PF-specific marker vesicu-
lar glutamate transporter 1 (VGlut1) (20) dropped from P8 to P15 in 
WT animals but stayed the same in Pkn1–/– animals (Supplemental 
Figure 1A; supplemental material available online with this article; 
https://doi.org/10.1172/JCI96165DS1), further showing imbal-
ances in CF/PF innervation. VGlut1 expression was consistently 
lower in Pkn1–/– animals during development (Supplemental Figure 
1A). Starting at P15, we detected dendritic thickening of Pkn1–/– PCs 
that coincided with the defective CF growth (Supplemental Fig-
ure 1B). At these early developmental stages, those defects did not 
translate into altered cerebellar morphology of Pkn1–/– mice. WT 
and Pkn1–/– mice showed a similar cerebellar size, foliation pattern, 
and thickness of the external granule layer (EGL), internal granule 
layer (IGL), and molecular layer (ML) (Supplemental Figure 1C).
To reveal potential CF synapse elimination deficits in Pkn1–/– 
animals, we measured CF-induced excitatory postsynaptic 
currents (ePSCs) in PCs in acute slices prepared from P15–P17 
animals (24). With gradually increasing stimulus intensities, the 
majority of ePSCs of WT PCs were obtained in an all-or-none 
fashion, while the majority of ePSCs of Pkn1–/– PCs occurred at 2 
or more discrete steps (Figure 1D). This indicates a more frequent 
occurrence of multiple CF innervation in Pkn1–/– mice.
To further expose a functional defect in PF-PC synapse for-
mation, we recorded spontaneous ePSCs of PCs in acute slices 
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NeuroD2 levels (Figure 3E). Additionally, we detected enhanced 
Cbln1 expression upon inhibition of AKT (Supplemental Figure 
3C). MK-2206 had similar effects in Pkn1–/– Cgcs (Supplemen-
tal Figure 3D). Furthermore, Pkn1–/– Cgcs showed a trend toward 
reduced Cbln1 levels (Supplemental Figure 3E). To further val-
idate those results, we next suppressed AKT expression in order 
to see whether the observed phenotype of Pkn1–/– Cgcs could be 
restored to WT levels.
siRNA-mediated knockdown of Akt123 restores axonal length, 
NeuroD2 expression levels, and the density of presynaptic sites in 
Pkn1–/– Cgcs to WT levels. WT and Pkn1–/– Cgcs were transfected 
with siRNAs targeting Akt123 or control nontargeting siRNAs and 
stained for pan-AKT. Akt123 siRNAs significantly reduced pan-
AKT expression at DIV1 and DIV4 (Figure 4A and Supplemental 
Figure 4, A and B). The concentration of Akt siRNAs was chosen to 
accomplish a significant decrease in AKT without adverse effect 
on cell viability. Knockdown of Akt123 significantly reduced the 
enhanced axonal length of Pkn1–/– Cgcs at DIV1 (Figure 4B). Sim-
MK-2206 (Supplemental Figure 3A). MK-2206 reduced the axonal 
length of Pkn1–/– Cgcs to WT levels (Figure 3B), establishing PKN1 
as a regulator of axonal length upstream of AKT.
Interestingly, we found that mature Pkn1–/– Cgc cultures had 
higher NeuroD2 protein levels (Figure 3C). Transfection of Pkn1–/– 
Cgcs with hPKN1, but not with GFP (Supplemental Figure 3B), 
reduced the mean NeuroD2 intensity in immunofluorescence stain-
ings (Figure 3D), establishing PKN1 as a negative regulator of Neuro-
 D2 levels. This fits well with our observation of a defective spacing of 
presynaptic sites in Pkn1–/– Cgcs (Figure 2B), since NeuroD2 is a tran-
scription factor preventing presynaptic differentiation, whose over-
expression reduces the density of presynaptic sites in Cgcs (30). Since 
AKT has been shown to enhance the activity of several transcription 
factors regulating NeuroD2 expression, such as neuro genin 1 and 
neuronal differentiation-1 (NeuroD1) (35, 36), we next tested whether 
AKT regulates NeuroD2 protein levels in Cgcs.
In protein extracts of WT Cgcs at DIV1 treated with MK-2206 
for 24 hours, we found that MK-2206 dose-dependently reduced 
Figure 1. Pkn1–/– mice show a defective PF-PC synapse formation during development. (A) Cerebellar vermis sections of P8–P15 animals (n = 4–12). Arrows 
mark distal and perisomatic varicosities of VGlut2-stained CFs. Scale bar: 50 μm. (B) The ratio of the VGlut2-stained CF innervation depth (μm) to the ML 
thickness (μm) was analyzed [1-way ANOVA with Newman-Keuls multiple-comparisons test, F(3,27) = 16.7, P < 0.0001, post-test *P < 0.05, **P < 0.01,  
***P < 0.001; n = 4 WT, 4 Pkn1–/– animals for P8, n = 12 WT, 11 Pkn1–/– animals for P15 from 5–8 litters per group]. (C) The score of PC perisomatic VGlut2  
staining in P15 animals [χ2 test = 4.286, P = 0.0384, n = 5 WT, 5 Pkn1–/– animals from 5 litters per group]. (D) CF-induced ePSCs were recorded from PCs in 
acute slices. With increasing stimulation strength, ePSCs were obtained in an all-or-none fashion (single CF) or in 2 or more discrete steps (multiple CFs) 
[χ2 test = 9.68, P = 0.0019, n = 23 WT, 23 Pkn1–/– cells from 7 P15–P17 animals per group]. (E) Spontaneous PC ePSC frequencies [2-tailed unpaired t test with 
Welch’s correction, t(5) = 2.865, *P = 0.0352, n = 6 WT, 4 Pkn1–/– cells from 3–5 P13–P15 animals per group]. (F) Western blot analysis of Cbln1 and GluD2 
levels (n = 3–4). (G and H) Analysis of the Cbln1/tubulin ratio (G) [2-tailed unpaired t test, t(5) = 3.365, *P = 0.0200, n = 3 WT, 4 Pkn1–/– extracts from 3–4 
animals per group] and GluD2/tubulin ratio (H) [2-tailed unpaired t test, t(5) = 1.016, P = 0.3561, n = 3 WT, 4 Pkn1–/– extracts from 3–4 animals per group] in 
P15 animals. Data are presented as individual n values with mean ± SEM. All analyses/experiments except F–H were performed in a blinded manner.
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ping and AKT phosphorylation increasing during development 
(Figure 5A). Concomitantly we found higher AKT phosphory-
lation in Pkn1–/– cerebella protein lysates (Supplemental Figure 
5A) and in immunofluorescence stainings (Figure 5, B and C). 
AKT phosphorylation levels were particularly increased in areas 
and developmental stages of axonal outgrowth and maturation 
of Cgcs and dendritic outgrowth and maturation of PCs. At 
P8 Pkn1–/– animals showed higher AKT phosphorylation in the 
PF-forming Cgcs of the premigratory EGL, where Cgcs start 
extending axons, as well as in the IGL (Figure 5B). At P15, higher 
AKT phosphorylation was found in the IGL and in PC dendrites 
(Figure 5C). In agreement with greater AKT activity, we found 
increased NeuroD2 protein levels in Pkn1–/– cerebellar protein 
extracts (Figure 5D). There were no differences in AKT phos-
phorylation or NeuroD2 levels in adult animals (Supplemental 
ilarly, elevated NeuroD2 levels in Pkn1–/– Cgcs were restored to 
WT levels upon Akt123 knockdown (Figure 4C) and accompanied 
by an increased density of presynaptic sites (Figure 4D). Knock-
down of Akt123 also resulted in an enhanced expression of Cbln1 
in WT (Supplemental Figure 4C) and Pkn1–/– Cgcs (Supplemental 
Figure 4D). These data confirm our previous findings that PKN1- 
mediated modulation of AKT is crucial for the balance between 
axonal outgrowth, NeuroD2/Cbln1 expression, and presynaptic 
differentiation. We therefore next tested AKT phosphorylation 
and NeuroD2 expression during in vivo development in WT and 
Pkn1–/– animals.
Cerebellar alterations in Pkn1–/– mice coincide with develop-
mentally enhanced AKT phosphorylation and NeuroD2 expres-
sion in vivo. Protein lysates prepared from P1–P15 WT cerebella 
showed an inverse correlation between PKN1 expression drop-
Figure 2. Pkn1–/– Cgcs have a reduced density of presynaptic sites and enhanced axonal outgrowth. (A) In WT Cgcs, TAU-stained axonal en passant 
swellings colocalized with the presynaptic marker synapsin I (images were taken at DIV4 and are representative of at least 3 separate experiments in WT 
and Pkn1–/– Cgcs). (B) The number of en passant swellings (varicosities) per axonal section was analyzed in WT and Pkn1–/– Cgcs at DIV7 [2-tailed unpaired 
t test, t(6) = 4.413, **P = 0.0045, n = 4 WT, 4 Pkn1–/– Cgc preparations from 4 litters per group]. (C) Pkn1–/– Cgcs were transfected with GFP together with a 
control HA-plasmid (Co-HA) or human HA-tagged PKN1 (hPKN1), and varicosities per axonal section were analyzed at DIV7 in GFP-expressing/TAU-stained 
Cgcs [2-tailed unpaired t test, t(4) = 7.147, **P = 0.002, n = 3 from 3 litters]. (D) Axonal length after DIV1 [2-tailed unpaired t test, t(5) = 4.431, **P = 0.0068, 
n = 4 WT, 3 Pkn1–/– Cgc preparations from 3–4 litters per group] and DIV7 [2-tailed unpaired t test, t(6) = 2.692, *P = 0.0360, n = 4 WT, 4 Pkn1–/– Cgc prepara-
tions from 4 litters per group] in TAU-stained Cgcs. (E) Pkn1–/– Cgcs were transfected with GFP together with Co-HA or hPKN1, and axonal length at DIV7 was 
analyzed in GFP-expressing/TAU-stained Cgcs [2-tailed unpaired t test, t(4) = 4.752, **P = 0.0090, n = 3 from 3 litters]. GFP-expressing cells also expressed 
hPKN1, as seen in overlapping GFP/HA staining (image is representative of 3 separate experiments). Data are presented as individual n values with mean ± 
SEM. Cgcs were grown on laminin-coated coverslips, and representative WIS-NeuroMath–analyzed output images are shown in D and E. All scale bars: 50 μm.  
Experimenters were not blinded to the genotype or treatment.
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ML (Figure 6, A and D). The facts that the proliferative layer of 
the EGL in young animals was similar between both genotypes 
(Supplemental Figure 6A) and that there were no ectopic NeuN- 
positive cells in the ML of adult Pkn1–/– cerebella (Supplemental 
Figure 6B) rule out a defective proliferation/migration of Pkn1–/– 
Cgcs as the underlying mechanism. In further agreement with 
a defective PF-PC synapse formation, we saw no significant PC 
degeneration in 3- to 9-month-old animals, but we found a late- 
onset loss of PCs in Pkn1–/– mice older than 15 months (Figure 6E).
Adult Pkn1–/– mice still showed abnormal CF innervation, as 
seen in a significantly higher ratio of VGlut2/VGlut1 protein lev-
els (Figure 6F) and increased VGlut2 staining (Figure 6G). In WT 
animals, VGlut2-stained CF terminals showed a reduction in the 
number of varicosities from the proximal part of the PC dendrite 
to the distal part (Figure 6G and Supplemental Figure 6C). This 
was not seen in Pkn1–/– animals, where the number of varicosities 
remained the same throughout the entire innervation depth of 
CFs (Figure 6G and Supplemental Figure 6C). Additionally, PCs 
of adult Pkn1–/– animals still had thicker dendrites (Supplemental 
Figure 6D), showing that Pkn1 knockout–mediated defects of CF 
elimination and dendritic outgrowth persist throughout life.
Figure 5, B and C), showing a development-specific effect of 
Pkn1 knockout on AKT and NeuroD2.
These exciting results show, for the first time to our knowledge, 
that PKN1 controls AKT phosphorylation and NeuroD2 expres-
sion during cerebellar development in vivo, thereby explaining the 
defective PF-PC synapse formation and reduced Cbln1 expression 
levels upon Pkn1 knockout.
Interestingly, we also found that the enlarged dendritic cali-
ber of Pkn1–/– PCs could be reduced to WT levels upon incubation 
of organotypic slices with the AKT antagonist MK-2206, showing 
that PKN1 also controls PC dendritic caliber upstream of AKT 
(Supplemental Figure 5D). Therefore, we cannot exclude a PC- 
dependent defect, due to dendritic thickening upon Pkn1 knock-
out, that further weakens PF-PC synapse formation.
Adult Pkn1–/– animals show cerebellar degeneration. Several other 
studies have related a defective PF-PC synapse formation to 
a degeneration of Cgcs and a late-onset loss of PCs (22, 37). As 
compared with WT mice, adult (3–9 months old) Pkn1–/– mice still 
displayed a similar cerebellar foliation pattern, but Pkn1–/– animals 
had smaller cerebella, as seen in a smaller sagittal vermis areas 
(Figure 6, A and B), with a thinner IGL (Figure 6, A and C) and 
Figure 3. Pkn1 knockout results in elevated AKT phosphorylation and NeuroD2 protein levels in Cgcs in vitro. (A) Phospho-AKT (p-AKT) [T308] intensity 
was measured in untransfected Pkn1–/– Cgcs and Pkn1–/– Cgcs expressing human HA-tagged PKN1 (hPKN1) [8–22 transfected cells were analyzed per exper-
iment; 2-tailed paired t test, t(2) = 5.365, *P = 0.033, n = 3 from 3 litters]. (B) Cgc axonal length was measured at DIV1 after 24 hours of treatment with the 
AKT inhibitor MK-2206 (1 or 5 μM) in TAU-stained Cgcs [1-way ANOVA with Newman-Keuls multiple-comparisons test, F(5,15) = 26.97, P < 0.0001, post-
test **P < 0.01, ***P < 0.001; n = 3–4 WT, 3–4 Pkn1–/– Cgc preparations from 3–4 litters per group]. (C) NeuroD2 expression levels were analyzed in Cgcs 
at DIV6–8 [2-tailed unpaired t test, t(11) = 3.228, **P = 0.008, n = 7 WT, 6 Pkn1–/– Cgc preparations from 6–7 different litters]. Representative WIS-Neuro-
Math–analyzed output images are shown. (D) NeuroD2 intensity was measured at DIV4 in untransfected Pkn1–/– Cgcs and Pkn1–/– Cgcs expressing hPKN1 
[26–32 transfected cells were analyzed per experiment; 2-tailed paired t test, t(2) = 4.904, *P = 0.0392, n = 3 from 3 litters]. (E) WT Cgc protein extracts at 
DIV1 were analyzed for the effect of 24 hours of treatment with MK-2206 on NeuroD2 protein levels [1-way ANOVA with Newman-Keuls multiple-compar-
isons test, F(2,8) = 11.76, P = 0.0042, post-test **P < 0.01, n = 3–4 from 3–4 litters]. All data are presented as individual n values with mean ± SEM. Scale 
bars: 10 μm in A and D, 50 μm in B. Experimenters were not blinded to the genotype or treatment.
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Behavioral phenotyping of adult Pkn1–/– mice reveals an ataxia-like 
phenotype. Considering the important role of the cerebellum in bal-
ance and motor control, we tested a cohort of adult (4–9 months) 
WT and Pkn1–/– mice in a set of refined motor behavior tests. 
Pkn1–/– mice showed an abnormal performance in the vertical pole 
test. While the majority of WT mice turned around and climbed 
down, most Pkn1–/– mice fell down, slid sideways, or froze on the 
pole (Figure 7A), indicating balance and motor coordination prob-
lems. In line with this, Pkn1–/– mice were slower than WT mice in 
crossing a horizontal beam (Figure 7B) and showed more slips and 
balance coordination problems than WT mice in the ledge test (Fig-
ure 7C). Moreover, Pkn1–/– mice exhibited hind-limb clasping, a sign 
of neurodegeneration (38), with most animals having one hind limb 
partly retracted toward the body (Figure 7D). While the grip 
strength in the wire hang test was not different between the groups, 
the hind-limb grip duration was significantly reduced in Pkn1–/– 
mice, with most mice turning in circles and not being able to grab 
the wire properly (Figure 7E). Footprint analysis further indicated 
that Pkn1–/– mice preferred tip toe walking and showed a reduced 
toe spread score (Figure 6F). General locomotion in the open field 
test was similar between WT and Pkn1–/– mice (Supplemental Fig-
ure 7A). Likewise, anxiety-related behavior tested in the elevated 
Figure 4. siRNA-mediated Akt knockdown reduces axonal length and NeuroD2 protein levels and increases the density of presynaptic sites in Pkn1–/– 
Cgcs. (A) siRNAs targeting Akt123 reduce pan-AKT expression after DIV1. Pictures are representative of 5 separate experiments. For analysis at DIV1 and 
DIV4 in WT and Pkn1–/– Cgcs, see Supplemental Figure 4, A and B. (B) siRNAs targeting Akt123 significantly reduce axonal length of Pkn1–/– Cgcs at DIV1 
[1-way ANOVA with Newman-Keuls multiple-comparisons test, F(3,16) = 20.78, P < 0.0001, post-test ***P < 0.001, n = 5 WT, 5 Pkn1–/– Cgc preparations 
from 3–5 litters per group]. Axons were stained with TAU. Representative WIS-NeuroMath–analyzed output images are shown. (C) siRNAs targeting Akt123 
significantly reduce NeuroD2 intensity in WT and Pkn1–/– Cgcs at DIV4 [1-way ANOVA with Newman-Keuls multiple-comparisons test, F(3,16) = 18.73,  
P < 0.0001, post-test *P < 0.05, ***P < 0.001; n = 5 WT, 5 Pkn1–/– Cgc preparations from 3–5 litters per group]. (D) Presynaptic sites (varicosities) were stained 
with TAU and synapsin I. Insets represent higher-magnification single- and double-labeled examples of axonal varicosities (indicated by arrows). White 
varicosities in double-labeled insets demonstrate TAU and synapsin I colocalization. siRNAs targeting Akt123 significantly increase the density of presynap-
tic sites in Pkn1–/– Cgcs at DIV4 [1-way ANOVA with Newman-Keuls multiple-comparisons test, F(3,16) = 16.62, P < 0.0001, post-test ***P < 0.001, n = 5 WT, 5 
Pkn1–/– Cgc preparations from 3–5 litters per group]. All data are presented as individual n values with mean ± SEM. Scale bars: 50 μm, except in inset in D:  
10 μm. Experimenters were not blinded to the genotype or treatment.
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plus maze was not affected by Pkn1 knockout (Supplemental Fig-
ure 7B). Therefore, these behavioral tests revealed that Pkn1–/– mice 
show normal locomotor activity but have problems with balance 
and motor coordination and display signs of mild ataxia, such 
as hind-limb clasping and gait abnormalities. Interestingly, the 
behavioral abnormalities of Pkn1–/– mice start before an obvious PC 
loss (Figure 6E), suggesting synaptic dysfunctions and Cgc degen-
eration rather than PC degeneration as the underlying mechanism.
Discussion
Data presented here shed light on the largely unknown 
brain-specific functions of PKN1. We demonstrate that PKN1 
is an important gatekeeper of intrinsic AKT activity during 
cerebellar development in vivo. We propose a mechanism by 
which PKN1-mediated AKT inhibition during PF growth (P4–
P15) results in a reduction of NeuroD2 levels and a subsequent 
increase in presynaptic specifications and Cbln1 expression in 
Cgcs, which is essential for a correct PF-PC synapse formation 
and cerebellar long-term function.
Accordingly, Pkn1–/– animals have an impaired developmental 
regression of CFs, persistent multiple CF innervation, and a reduced 
spontaneous ePSC frequency of PCs, all indicative of a defective 
PF-PC synapse formation (Figure 1). Spontaneous PC activity in 
vitro is highly temperature sensitive and is inhibited at room tem-
perature (25); therefore ePSCs recorded in our setting most likely 
arise from extrinsic input. Since the ratio of PF to CF synapses in 
the PC is on the order of 150:1 (39), it is generally assumed that 
most spontaneous ePSCs reflect PF activity (26, 27). Defective CF 
elimination and reduced spontaneous PC activity are also seen in 
animals lacking the Cbln1 or GluD2 gene, both of which are needed 
for a correct PF-PC synapse formation (22, 28, 37). Interestingly, we 
found a reduced Cbln1 expression in Pkn1–/– animals, while GluD2 
levels were only marginally affected, pointing toward a presynaptic 
Cgc-specific defect in PF-PC synapse formation.
Using in vitro Cgc cultures, we could show that Pkn1 knockout 
leads to enhanced AKT phosphorylation and subsequently higher 
NeuroD2 protein levels. Cbln1 and NeuroD2 levels are reciprocally 
regulated by AKT in vitro, with decreased NeuroD2 and increased 
Cbln1 levels upon AKT inhibition, further showing that in Cgcs 
AKT is involved in controlling presynaptic differentiation. Subse-
quently, Pkn1 knockout results in enhanced axonal outgrowth and 
reduced presynaptic differentiation in Cgcs in vitro, both of which 
could be restored to WT levels upon inhibition of AKT. In line with 
our in vitro data, Pkn1–/– animals showed pronounced AKT phos-
phorylation and higher NeuroD2 levels at developmental stages 
critical for PF growth and synapse maturation. Throughout cer-
ebellar development NeuroD2 is expressed only in Cgcs and ML 
interneurons, not in PCs (40, 41), and owing to the relatively low 
ML interneuron numbers compared with Cgcs, our analysis of 
protein extracts mainly reflects Cgc protein levels. NeuroD2 levels 
are particularly high during phases of axon growth in which it pre-
vents premature presynaptic maturation, but are degraded with 
increasing developmental maturation in order to drive presynap-
tic differentiation (30). Accordingly, NeuroD2 expression is tightly 
Figure 5. Pkn1–/– cerebella show elevated AKT 
phosphorylation and NeuroD2 protein levels during 
developmental stages of PF maturation. (A) There was 
a significant correlation between the p-AKT [S473]/AKT 
ratio and the PKN1/GAPDH ratio in cerebellar protein 
extracts from P1–P15 WT animals (Pearson correlation, 
number of XY pairs: 4, Pearson r = –0.9990, 2-tailed, 
 P = 0.001, R2 = 0.9979, n = 3–4 from 3–4 litters per 
group). Data are presented as mean ± SEM. (B and C) 
Confocal images of cerebellar sections of P8 and P15 
WT and Pkn1–/– animals stained for p-AKT [S473] and 
Hoechst (P8) (B) or p-AKT [S473] and VGlut2 (P15) (C). 
Pictures are representative of at least 3 independent 
experiments. (D) Western blot analysis of NeuroD2 
expression in P8 [2-tailed unpaired t test, t(9) = 2.546, 
*P = 0.0314, n = 5 WT, 6 Pkn1–/– animals from 4–5 dif-
ferent litters] and in P15 WT and Pkn1–/– whole cerebella 
protein extracts [2-tailed unpaired t test, t(6) = 2.541,  
**P = 0.0440, n = 4 WT, 4 Pkn1–/– animals from 4–5 dif-
ferent litters]. Data are presented as individual n values 
with mean ± SEM. All scale bars: 50 μm. Experimenters 
were not blinded to the genotype.
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expressing both proteins (43); therefore we cannot exclude that 
despite higher NeuroD2 protein levels in Pkn1–/– cerebella, the lack 
of PKN1 additionally affects NeuroD2 function. However, the fact 
that Pkn1–/– Cgcs show a reduced density of presynaptic sites, a typi-
cal effect of NeuroD2 (30), points toward normal NeuroD2 activity.
Many neurological disorders have been linked with aberrant 
AKT signaling caused by germline mutations of certain tumor 
suppressor genes such as phosphatase and tensin homolog (Pten) 
or tuberous sclerosis proteins 1 and 2 (Tsc2/Tsc1) (44–46). Inter-
estingly, a partial knockout of disabled homolog 2–interacting 
controlled, since an increase in NeuroD2 decreases cell-intrinsic 
neuronal excitability (42). Our data offer pioneering evidence 
on a developmentally regulated PKN1-AKT axis that controls 
NeuroD2 levels and subsequently the precise balance between 
axonal growth and presynaptic differentiation of Cgcs. Deletion of 
Pkn1 therefore interferes with the correct PF-PC synapse forma-
tion (Figures 1–5) and results in cerebellar atrophy in adult animals 
(Figures 6 and 7).
The truncated C-terminal fragment of PKN1 enhances Neuro-
D2-mediated transcription in vitro and in mammalian cells over-
Figure 6. Adult Pkn1–/– mice show cerebellar shrinkage and late-onset PC degeneration. (A) Size differences of adult WT and Pkn1–/– cerebella (3–9 
months), as seen in Hoechst-stained sagittal vermis sections and calbindin-stained ML pictures (representative images of 8–11 separate experiments).  
(B–D) Analysis of the cerebellar vermis area (B) [2-tailed unpaired t test, t(15) = 2.510, *P = 0.0236, n = 9 WT, 8 Pkn1–/– animals from 4–6 litters per group], the 
IGL thickness (C) [2-tailed unpaired t test with Welch’s correction, t(12) = 2.772, *P = 0.0169, n = 11 WT, 8 Pkn1–/– animals from 4–5 litters per group], and the 
ML thickness (D) [2-tailed unpaired t test, t(17) = 3.210, **P = 0.0051, n = 11 WT, 8 Pkn1–/– animals from 4–5 litters per group] in 3- to 9-month-old animals. 
(E) PC number in 3- to 9-month-old and 15- to 22-month-old animals [1-way ANOVA with Newman-Keuls multiple-comparisons test, F(3,38) = 23.12,  
P < 0.0001, post-test **P < 0.01, ***P < 0.001; n = 5–15 WT, 7–15 Pkn1–/– animals]. (F) Cerebellar protein extracts from 3- to 9-month-old animals were ana-
lyzed for the VGlut2/VGlut1 ratio [2-tailed unpaired t test, t(7) = 4.138, **P = 0.0044, n = 4 WT, 5 Pkn1–/– animals from 4 litters per group]. (G) Calbindin- and 
VGlut2-stained cerebellar sections of 3- to 9-month-old animals (representative images of 11–12 experiments; see Supplemental Figure 6C for analysis). All 
data are presented as individual n values with mean ± SEM. Scale bars: A, Hoechst, 500 μm; calbindin, 50 μm; E and G, 100 μm. All analyses were performed 
by experimenters blinded to the genotype, except F.
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sion (P4–P15; Supplemental Figure 5A and Figure 5) may serve 
as a direct explanation for this discrepancy. Despite the rapidly 
increasing literature on AKT signaling and neurodevelopment, 
this is, to our knowledge, the first report linking developmental 
AKT activity with NeuroD2 levels and PF-PC synapse formation, 
and we offer PKN1 as a regulator of this pathway. The detailed elu-
cidation of the molecular mechanism of AKT-mediated increase 
in NeuroD2 protein levels, such as whether AKT enhances Neuro-
 D2 expression via enhancement of neurogenin 1 or NeuroD1 tran-
scriptional activity (35, 36, 51) or else protects its proteolytic deg-
radation, remains to be solved in future investigations.
Another well-characterized effect of a defective PF-PC syn-
apse formation is a late-onset degeneration of Cgcs and PCs (22, 
protein (Dab2ip), a molecule that shifts the balance of PI3K/AKT– 
mediated cell survival toward apoptosis signal–regulating kinase 
1–mediated (ASK1-mediated) apoptosis, has a similar phenotype 
to Pkn1–/– mice (47). Dab2ip-knockdown mice show aberrant PC 
dendrite maturation and a defective balance of CF/PF synaptic 
markers. Pkn1–/– mice also show some overlapping features with 
mice with a deletion of Pten (48–50). These include increased 
AKT phosphorylation, abnormal axonal outgrowth, enhanced 
presynaptic spacing, dendritic thickening, reduction of ML thick-
ness, degeneration of PCs, and deficits in motor coordination 
(48–50). However, Pkn1–/– and Pten–/– phenotypes differ in other 
aspects, such as brain enlargement and enlarged cell somata. The 
tight developmental regulation of PKN1-mediated AKT suppres-
Figure 7. Adult Pkn1–/– animals have problems with balance and motor coordination. A cohort of adult (4–9 months) WT and Pkn1–/– animals was examined 
for motor deficits in a set of behavioral tests. (A) Adult mice were tested in the vertical pole task [χ2 test (3) = 42.33, P < 0.0001, n = 11 WT, 12 Pkn1–/– animals 
from 4–6 litters per group]. Data are presented as mean percentage. (B) Animals were tested in the balance beam test [2-tailed unpaired t test with Welch’s 
correction, t(15) = 2.328, *P = 0.0334, n = 11 WT, 12 Pkn1–/– animals from 4–6 litters per group]. (C) Animals were scored in the ledge test [χ2 test (1) = 7.441,  
P = 0.0064, n = 11 WT, 12 Pkn1–/– animals from 4–6 litters per group]. (D) Animals were scored for hind-limb clasping [χ2 test (2) = 8.767, P = 0.0125, n = 11 WT, 
12 Pkn1–/– animals from 4–6 litters per group]. (E) In the wire hang test, the grip strength, as determined by the latency to fall [2-tailed unpaired t test, t(21) 
= 0.1352, P = 0.8938, n = 11 WT, 12 Pkn1–/– animals from 4–6 litters per group] and hind-limb grip duration [2-tailed unpaired t test, t(19) = 2.724, *P = 0.0135, 
n = 9 WT, 12 Pkn1–/– animals from 4–6 litters per group], was assessed. (F) Footprints were scored for tip toe walking [χ2 test (1) = 9.763, P = 0.0018, n = 11 WT, 
12 Pkn1–/– animals from 4–6 litters per group] and toe spread [χ2 test (2) = 6.345, P = 0.0419, n = 11 WT, 12 Pkn1–/– animals from 4–6 litters per group]. Data in B 
and E are presented as individual n values with mean ± SEM. Experimenters were not blinded to the genotype, except in F.
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the mice could walk on the whole foot (paw and toes) and then scored 
the gait for how they preferred to walk (tip toes or whole foot). We cal-
culated the toe spread score by assigning values between 0 (narrowest 
spread) and 2 (widest spread).
Paraformaldehyde perfusion. Mice were deeply anesthetized by an 
overdose of thiopental (150 mg/kg), and brains were fixed by tran-
scardial perfusion with PBS (50 mM PBS, pH 7.2; 2 minutes) followed 
by 4% paraformaldehyde (PFA) in PBS (10 minutes).
Preparation of cerebellar granule cells. Cgcs were prepared as 
described previously (58). Cells were kept in Neurobasal medium 
(Thermo Fisher Scientific) supplemented with 1% penicillin/ 
streptomycin/glutamine (Sigma-Aldrich), 2% B-27 (Thermo Fisher 
Scientific), and an additional 20 mM KCl. Coverslips and dishes were 
coated with poly-l-ornithine or poly-l-lysin (2 hours to overnight; 
Sigma-Aldrich), and for coverslips laminin (10 μg/ml; Sigma-Aldrich) 
was subsequently added for 2–3 hours at 37°C. MK-2206 (Santa Cruz 
Biotechnology) was added 2–3 hours after preparation.
Transfections of cerebellar granule cells. Nucleofection (Lonza) of 
Cgcs was performed as described previously (59) with 5 μg plasmid 
DNA and, if indicated, together with 3 μg pmax GFP plasmid (Lonza) 
using program G-013. Human PKN1 (hPKN1) was purchased from 
GeneCopoeia and subcloned into the mammalian expression vector 
pEF-neo. For Lipofectamine transfections, 2 μl Lipofectamine (Thermo 
Fisher Scientific) and 0.9 μg plasmid DNA were mixed with Neuro-
basal medium and added to coverslips for 6–8 hours. The medium 
was then exchanged for the preconditioned culture medium, and 
cells were analyzed after 48 hours. Akt123 and control siRNAs were 
purchased from Dharmacon. For siRNA transfections, 101 nM of each 
Akt siRNA (303 nM in total) and 303 nM control, nontargeting siRNAs 
were transfected with program G-013 or program O-005, both of 
which yielded similar results. Using higher siRNA concentrations 
resulted in cell death upon Akt knockdown (data not shown). Trans-
fections of the same Cgc preparation with 2 different programs were 
counted as separate experiments.
Cryosectioning. P1, P4, P8, P15, and adult brains were fixed in 4% 
PFA for 2.5 hours (P1, P4, and P8), for 5 hours (P15), overnight (adult 
brains), or by PFA perfusion. Brains were incubated in a sucrose gradient 
(10% sucrose for 2 hours, 20% sucrose overnight, and 30% sucrose for 
a minimum of 2 days), embedded in OCT compound (Thermo Fisher 
Scientific), and stored at –80°C until analysis. Twenty-micrometer-thick 
sections were cut with a cryostat (CM1950, Leica), transferred onto 
lysine-coated coverslips (Sigma-Aldrich), and allowed to dry for 2 hours 
at room temperature for further analysis or stored at –20°C. In order to 
ensure comparable results, age-matched WT and Pkn1–/– sections were 
prepared on the same day and transferred onto the same coverslip.
Immunofluorescence staining. Cells were fixed (4% PFA 15 minutes, 
methanol 30 seconds at –20°C), permeabilized (0.3% Triton X-100, 15 
minutes), and blocked (1% BSA, 2% goat serum, 1 hour). For cerebellar 
sections, permeabilization was 30 minutes and a higher blocking solu-
tion was used (10% goat serum, 2% BSA, 1 hour). For VGlut2 and p-AKT 
T308 staining of cerebellar sections, we performed antigen retrieval in 
a 10-mM sodium citrate buffer, pH 6, with 0.05% Tween-20 (100°C 
for 10 minutes). Primary antibodies (diluted in 0.1% Triton X-100, 1% 
BSA, 2% goat serum in PBS) were added at 4°C overnight. After wash-
ing in PBS, secondary antibodies (goat anti-rabbit–Alexa Fluor 488 and 
goat anti-mouse–Alexa Fluor 555) were added for 2–4 hours at room 
temperature. Coverslips/sections were washed in PBS and embedded 
37). In agreement with that, we show that the long-term effect of 
Pkn1 knockout results in cerebellar shrinkage and PC degeneration 
and is accompanied by gait abnormalities, hind-limb clasping, and 
motor coordination problems (Figures 6 and 7), reminiscent of mild 
cerebellar ataxia (18). Interestingly, recent studies have connected 
microdeletions on chromosome 19p13.12, including PKN1, to human 
cerebellar hypoplasias and psychomotor delays (52–55). It has there-
fore been suggested that one or more of the genes on chromosome 
19p13.12 have a role in the control of movements (55), and our results 
establish PKN1 as a promising new candidate gene for this.
Methods
Further information can be found in Supplemental Methods, available 
online with this article; https://doi.org/10.1172/JCI96165DS1. 
Animals. The generation of Pkn1-knockout mice (Pkn1–/– mice) has 
been described recently (17). Mice were backcrossed to C57BL/6N for 
more than 8 generations. C57BL/6N WT and C57BL/6N Pkn1–/– animals 
were derived from the same heterozygous crosses and then bred sepa-
rately, but kept under the same housing and experimental conditions in 
the same room. C57BL/6N were derived from The Jackson Laboratory.
Behavioral phenotyping. Experiments were performed in a cohort 
of adult (3–9 months) WT (n = 11) and Pkn1–/– (n = 12) animals between 
8 am and 1 pm.
Hind-limb clasping. Mice were lifted for 10–20 seconds by grasp-
ing of their tail, and movement of hind limbs was scored as previously 
described (56). Hind-limb clasping was assessed 3 times; the mean 
score was calculated and rounded up or down to the full score. In case 
of 0.5 or 1.5 the score was downgraded to 0 or 1.
Ledge test. For the ledge test, mice were lifted from their home 
cage and placed on another cage ledge, as described previously (56). 
The test was repeated twice, and the mean score of both performances 
was calculated and rounded up or down to the full score. In case of 0.5 
or 1.5 the score was downgraded to 0 or 1.
Pole climb. The task for the mice in this test was to turn around 
and climb down from the top of a vertical pole (1 cm diameter, 60 cm 
height) within 120 seconds. The behavior on the pole (climbing down, 
sliding down sideways, freezing on the column for more than 120 sec-
onds, or falling down) was assessed in 3 different trials, and the per-
centage of each behavior for each mouse was analyzed.
Beam walk. Motor coordination and balance were assessed by mea-
surement of the ability of the mice to traverse a narrow 18-mm-wide, 
9-mm-high, 2-m-long beam. Mice were placed in the middle, 70 cm 
above the ground. Illumination was set to 150 lux. The latency to tra-
verse the beam to the safety platform was recorded for 2 trials, and the 
mean was calculated.
Wire hang. The animal was placed on a wire cage lid, which was 
then inverted and suspended above the home cage after a modified 
method (57). The cage lid was kept at 40 cm above a cage filled with 
soft material. The latency for each animal to release the grip with a 
cutoff time of 150 seconds as well as the hind-limb grip duration was 
recorded. The latter was performed on video recordings of 9 WT and 
12 Pkn1–/– animals.
Footprint analysis. The entire forelimbs of mice (paw and toes) 
were painted in red body paint, and the entire hind limbs were painted 
in blue body paint. Mice were released onto a white paper cardboard 
into a metal tunnel (6 × 70 cm) and allowed to walk to the other end 
into a safe cage. For assessment of tip toe walking, we made sure that 
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kept for a maximum of 8 hours. Whole-cell patch recordings were 
performed on visually identified PCs in lobulus IV/V using a ×20 
water immersion objective (Olympus) with an additional ×2 mag-
nifier as described previously (62). Briefly, slices were transferred 
to a submersion-style recording chamber mounted on an Olympus 
BXS1WI and superfused with standard aCSF, continuously bubbled 
with 95% O2/5% CO2 at room temperature, comprising (in mM): 
NaCl, 125; NaHCO3, 26; d-glucose, 10; KCl, 2.5; NaH2PO4, 1.43; 
CaCl2, 2; MgCl2, 1. The aCSF had an osmolality of 310 mOsm/kg. 
Patch pipettes were pulled from borosilicate capillaries (GB120F-10, 
Science Products) with a Sutter P-1000 puller; the resistance was 
typically 2–5 MΩ when filled with internal solution consisting of (in 
mM): K-gluconate, 132; EGTA/KOH, 1; MgCl2, 2; NaCl, 2; HEPES/
KOH, 10; Mg-ATP, 2; GTP, 0.5. The pH was adjusted to 7.2–7.25 with 
KOH, and the osmolality was 280–285 mOsm/kg. Recordings were 
obtained using a Multiclamp 700B amplifier and displayed with 
pClamp (Molecular Devices). In whole-cell configuration (holding 
potential –70 mV), series resistances were typically around 10–15 
MΩ. Cells were allowed to equilibrate for 10 minutes before record-
ing. Evoked CF inputs were triggered with a stimulation electrode 
filled with aCSF (resistance ~0.5 MΩ) that was placed 50–70 μm 
away from the recorded PC soma in the granule cell layer. The unipo-
lar square pulses with durations of 0.2 milliseconds were delivered 
at 0.1 Hz via a constant current stimulus isolator (World Precision 
Instruments A365). Stimulation current amplitudes were between 5 
μA and 100 μA. At least 3 discrete steps above triggering threshold 
with a step size of 10 μA were recorded in each cell. The CF synaptic 
inputs to the PCs were recorded at room temperature at a holding 
potential of –70 mV, low-pass-filtered at 10 kHz, and sampled at 20 
kHz. Data analysis was done in Matlab (Mathworks), and traces were 
analyzed by 2 different blinded experimenters. Spontaneous ePSCs 
and iPSCs were recorded at room temperature, low-pass-filtered at 
10 kHz, and sampled at 20 kHz; traces were low-pass-filtered after 
recordings at 1–4 kHz and analyzed with Clampfit module in pClamp.
Western blotting. Protein extracts and Western blotting were 
performed as described previously (59). Primary antibodies were 
added overnight in 5% BSA in TBS-T at 4°C, and secondary anti-
bodies (LI-COR) or HRP-tagged antibodies were added for 90 min-
utes in 5% milk in TBS-T. After washing in TBS-T, membranes were 
imaged and analyzed with Odyssey Infrared Imager (LI-COR) or 
ECL detection as described previously (63).
Antibodies. Clone numbers, where known, and catalog num-
bers are provided in parentheses. The p-AKT T308 antibody (catalog 
SAB4300043, further validated with MK-2206 in Cgcs; not shown) 
was from Sigma-Aldrich. The following antibodies were from Cell 
Signaling: ERK1/2 (catalog 9102), GAPDH (D16H11, catalog 5174), 
HA-Tag (C29F4, catalog 3724), NeuN (D4G40, catalog 24307), p-AKT 
S473 (Western blotting, D9E, catalog 4060), p-ERK1/2 (catalog 9101), 
pan-AKT (Western blotting, 40D4, catalog 2920), synapsin-I (D12G5, 
catalog 5297), and TAU (Tau46, catalog 4019). α-Tubulin (DM1A, cat-
alog ab80779), calbindin (catalog ab11426), calbindin (CB-955, catalog 
ab82812), cerebellin 1 (EPR13649, catalog ab181379), Ki-67 (catalog 
ab15580), p-AKT S473 (immunofluorescence staining, EP2109Y, cat-
alog ab81283, further validated with MK-2206 in Cgcs; not shown), 
AKT1/2/3 (immunofluorescence staining and Western blotting, 
EPR16798, catalog ab179463), and VGlut2 (8G9.2, catalog ab79157) 
were from Abcam. HA.11 (clone 16B12, catalog MMS-101P) was from 
in Mowiol (Sigma-Aldrich). Images were taken with a widefield (Axio, 
Zeiss) or laser scanning confocal microscope (SP5, Leica). For wide-
field microscopy the same exposure time and for confocal microscopy 
the same laser intensity were used to compare WT and Pkn1–/– sections. 
Confocal stacks were merged in ImageJ (NIH), and for better visual-
ization the intensity of calbindin and VGlut2 stainings was increased 
to the same extent using ImageJ. For comparison of p-AKT intensity, 
brain sections of WT and Pkn1–/– animals were prepared on the same 
day, transferred onto the same coverslip, and stained with the same 
antibody solution. Confocal images of at least 3 independent experi-
ments taken at the same exposure time are shown.
Analysis of cerebellar morphology. All analyses were performed in 
the cerebellar vermis area of cerebellar lobule IV/V in a blinded man-
ner using ImageJ. The mean vermis area was calculated from 2–6 sec-
tions per animal. The IGL thickness (3–5 measurements of 2–5 sections 
per animal) and ML thickness (3–5 measurements of 2–5 sections per 
animal) were measured at the thickest part of cerebellar lobule IV/V. 
The VGlut2/ML ratio was determined by 4–14 measurements of 1–2 
sagittal sections per animal. Perisomatic VGlut2 staining was scored 
by 2 experimenters in 1–2 confocal images per animal.
Measurement of axonal length and presynaptic spacing. Cgcs grown 
on laminin-coated coverslips were fixed at indicated time points and 
stained for TAU. Pictures were manually cleaned from background 
noise using ImageJ. Incomplete neurons as well as neurons with axons 
that crossed other axons (in that case the neuron with the shorter axon 
or the one that crossed more than 2 other axons was deleted) were 
erased. A minimum of 70 cells per coverslip (DIV1) and 20 cells per 
coverslip (DIV7) and a minimum of 21 GFP-positive transfected cells 
were analyzed with WIS-NeuroMath (60, 61). The number of presyn-
aptic varicosities per 50-μm axonal section was determined by 1–4 
measurements per axon from 24–42 cells per preparation.
Measurement of p-AKT and NeuroD2 intensity in transfected cerebel-
lar granule cells. Pkn1–/– Cgcs grown on laminin were Lipofectamine- 
transfected with hPKN1 on DIV5 and fixed and stained for HA and 
p-AKT T308 on DIV7. For NeuroD2 intensity measurements, nucle-
ofection was used to introduce hPKN1 in Pkn1–/– Cgcs immediately 
after preparation, and cells were then kept for DIV4 on laminin-coated 
coverslips. Cells were fixed and stained for NeuroD2 and HA. Images 
were taken with a widefield (Axio, Zeiss) microscope, and mean p-AKT 
or NeuroD2 levels were measured with ImageJ in the transfected 
(HA-positive) cell and the surrounding untransfected cells. Between 8 
and 32 transfected cells were analyzed and averaged per experiment. 
The average p-AKT or NeuroD2 intensity in untransfected cells was 
calculated from 3–15 cells surrounding the transfected cells per picture.
Electrophysiology. The age for spontaneous ePSC recordings was 
P13–P15 (WT average age of 13.7, Pkn1–/– mice average age of 15), and 
for CF-induced ePSCs, P15–P17 (WT average age of 15.7, Pkn1–/– mice 
average age of 15.2). Animals were anesthetized (isoflurane) and 
decapitated. Brains were gently removed and immediately chilled 
(~0°C) in high-glucose artificial cerebrospinal fluid (HiGluc-aCSF) 
containing (in mM): NaCl, 125; NaHCO3, 26; d-glucose, 25; KCl, 2.5; 
NaH2PO4, 1.43; CaCl2, 2; MgCl2, 1. The aCSF pH was adjusted to 7.4 
with a saturating carbogen mix (95 O2/5% CO2). Parasagittal cere-
bellar slices 300 μm thick were cut along the vermis with a vibratome 
(Leica VT1200S) in ice-cold HiGluc-aCSF. Slices were thereafter 
allowed to recover for at least 30 minutes in HiGluc-aCSF and bub-
bled with 95% O2/5% CO2 at room temperature until used and were 
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Other Scientific Purposes (ETS no. 123) (BMWFW-66.011/0040-WF/
V/3b/2016). Every effort was made to minimize the number of animals 
used. The study was designed in compliance with Animal Research: 
Reporting of In Vivo Experiments (ARRIVE) guidelines. Blinding was 
always performed by a third party, and every figure legend clearly states 
whether analysis was performed in a blinded or nonblinded manner.
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